Articles

The Missing IP Ledger: Where CPG Companies Leave Patent Value on the Table

Date: June 3, 2026

Key Takeaways

  • CPG companies often create patentable and protectable IP in packaging, formulation, manufacturing, sustainability, and brand-design work, not just in formal R&D.
  • Lost value usually comes from timing and process failures: public launch before filing review, weak supplier controls, missed design patents, poor marking, and overreliance on trade dress.
  • A practical IP capture process should connect protection decisions to margin, retailer strategy, copycat risk, licensing, diligence, and exit value.

Consumer packaged goods companies are good at measuring velocity, margin, distribution, shelf position, and repeat purchase. They are often less disciplined about measuring the intellectual property created while those numbers improve.

That gap matters. In CPG, the most valuable innovation is not always the headline product. It may be the closure that reduces leakage, the formulation tweak that stabilizes shelf life, the refill system that changes unit economics, the manufacturing step that saves twenty seconds per batch, the package geometry that makes a club-store pallet work, or the visual identity that turns a commodity into a premium item.

Those things can be protectable. They can also disappear into the business as "just operations," "just packaging," or "just marketing." By the time the company thinks about IP, the product has launched, the co-manufacturer has seen the process, the hero package has been photographed by retailers, the supplier agreement is already signed, and the one-year U.S. patent clock may already be running.

This is where CPG companies lose value: not because they lack innovation, but because they fail to convert operational and brand innovation into owned assets.


CPG Innovation Rarely Arrives Wearing a Lab Coat

Patent programs in CPG can fail when companies look only for laboratory breakthroughs. That is too narrow.

The protectable work often happens in cross-functional handoffs:
  • R&D changes a formula to improve mouthfeel, stability, bioavailability, fragrance retention, cleaning efficacy, or ingredient compatibility.
  • Packaging engineering changes a cap, fitment, valve, pouch, dispenser, applicator, label construction, tamper feature, shipping insert, refill cartridge, or case configuration.
  • Operations changes a mixing order, dwell time, temperature profile, filtration step, quality-control method, or line changeover process.
  • Brand and industrial design create a distinctive package silhouette, surface treatment, label placement, opening gesture, display system, or product look.
  • Sustainability teams redesign materials, concentrates, refill systems, package weights, and shipping formats.

Each of these can create business value. Some can support utility patents. Some are better protected as design patents, trade dress, trademarks, copyrights, or trade secrets. Some are best left unprotected because the cost or disclosure is not worth it. The point is not to patent everything. The point is to notice what the business is already creating and make deliberate choices.


Lost Opportunity 1: Treating Incremental Improvements as Non-Inventions

CPG teams often discount incremental work. "We just changed the ratio." "We just changed the package." "We just made it easier to fill." "We just solved a scaling problem."

That language can be expensive.

Patent law does not require an invention to be dramatic. It must satisfy the statutory requirements, including novelty and non-obviousness. See 35 U.S.C. §§ 102, 103. The obviousness analysis is flexible, and the Supreme Court has warned against a rigid formula for combining prior art. KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398 (2007). That flexibility cuts both ways. Some incremental changes will be obvious. Others will not, especially when they solve a known manufacturing, stability, sensory, compliance, or packaging constraint in a non-routine way.

The business test is not "does this feel like a Nobel Prize?" The better first-pass questions are:
  • Did this change solve a problem competitors also face?
  • Did it improve margin, yield, shelf life, compliance, shipping efficiency, consumer experience, or retailer acceptance?
  • Was the solution non-obvious to the technical or packaging team before testing?
  • Would a competitor copy it if they knew how it worked?
  • Can the company detect copying, or is secrecy a better path?

If the answer to several of those questions is yes, the company should at least evaluate the asset.


Lost Opportunity 2: Launching Before the Filing Strategy Is Set

CPG launch calendars move fast. Retail windows, trade shows, influencer seeding, Amazon listings, pitch decks, sell sheets, packaging renders, and retailer line reviews all create disclosure risk.

Under U.S. patent law, public use, sale, offers for sale, and public disclosures can become prior art. 35 U.S.C. § 102(a)(1). The U.S. has limited grace-period exceptions for certain inventor-originated disclosures. 35 U.S.C. § 102(b)(1). Many foreign jurisdictions are less forgiving. A product team that launches first and calls patent counsel later may have already narrowed or lost options.

The fix is operational, not dramatic. Build an IP checkpoint into the launch process:
  • before trade-show display;
  • before retailer sell-in materials go out;
  • before samples are sent without confidentiality controls;
  • before a co-manufacturer receives the full process;
  • before packaging renders are posted;
  • before a founder deck discloses the technical hook.

This does not have to slow the launch. Often the right move is a focused provisional filing, a design patent filing, a trade-secret decision, or a short memo documenting why no filing is needed. What hurts value is making none of those decisions before disclosure.


Lost Opportunity 3: Ignoring Design Patents for Packaging and Product Appearance

CPG companies spend heavily on product and packaging appearance because consumers buy with their eyes. Yet design patent filings are often missing from the IP plan.

A U.S. design patent can protect a "new, original and ornamental design for an article of manufacture." 35 U.S.C. § 171. For CPG, that may include bottles, caps, closures, dispensers, applicators, containers, product shapes, display elements, and other ornamental features tied to the article.

Design patents can be especially useful when the commercial value sits in a look that competitors can copy faster than the company can build trade-dress rights. They also have a damages statute worth taking seriously. Under 35 U.S.C. § 289, a design-patent infringer may be liable for its "total profit" from the infringing article of manufacture, subject to the limits addressed by the Supreme Court in Samsung Electronics Co. v. Apple Inc., 580 U.S. 53 (2016).

Design patents are not a substitute for utility patents or trademarks. But in CPG, they often protect a different layer of value: the consumer-facing design choices that make a product recognizable before brand loyalty has matured.

A practical rule: if the team would be angry to see the package, bottle, applicator, closure, or display copied by a private-label competitor six months after launch, evaluate design protection before the public reveal.


Lost Opportunity 4: Assuming Trade Dress Will Rescue an Unprotected Design

Trade dress can be powerful, but CPG companies sometimes overestimate how quickly it protects product design or packaging configuration.

Section 43(a) of the Lanham Act provides a federal cause of action for false designation of origin and trade dress infringement. 15 U.S.C. § 1125(a). But unregistered trade dress carries important limits. The statute places the burden on the claimant to prove that unregistered trade dress is not functional. 15 U.S.C. § 1125(a)(3). The Supreme Court has also held that product-design trade dress generally requires secondary meaning. Wal-Mart Stores, Inc. v. Samara Bros., Inc., 529 U.S. 205 (2000). And functional features are not protectable as trade dress. TrafFix Devices, Inc. v. Marketing Displays, Inc., 532 U.S. 23 (2001).

That matters for CPG packaging. A distinctive package may become protectable trade dress over time, but the early window after launch is when copycats can move quickly. If the design is important and new, design patents may cover the gap while brand recognition develops. If the feature is functional, trade dress may not be the right tool at all.

Color can sometimes function as a mark, as the Supreme Court recognized in Qualitex Co. v. Jacobson Products Co., 514 U.S. 159 (1995), but that does not mean every colorway, package cue, or product shape is immediately protectable. CPG companies should treat trade dress as part of a layered strategy, not a fallback for missed patent filings.


Lost Opportunity 5: Failing to Mark Patented Products

Even when a CPG company owns patents, it can lose damages leverage by failing to mark.

The patent marking statute limits damages recovery when patented articles are not properly marked. 35 U.S.C. § 287(a). In practical terms, a patent owner may be unable to recover damages for infringement before the infringer had actual notice, unless the product was properly marked.

This is not just a legal technicality. CPG companies change packaging constantly. Labels, cartons, inserts, QR codes, and digital product pages move through separate workflows. If patent marking is not built into packaging operations, it gets missed.

A useful marking program answers basic questions:
  • Which SKUs are covered by which patents?
  • Should the company use physical marking, virtual marking, or both?
  • Who updates marking when claims issue, expire, or no longer cover a product?
  • Does the same marking plan work for bundles, refill packs, seasonal packaging, private-label variants, and e-commerce listings?
  • Is the marking accurate enough to avoid creating false-marking risk?

The highest-value patent is less valuable if the company cannot preserve damages.


Lost Opportunity 6: Giving Away Manufacturing Know-How Through Weak Supplier Controls

CPG companies rely on co-manufacturers, packaging suppliers, formulation partners, agencies, flavor houses, industrial designers, and testing labs. Those relationships create IP every day.

They also create leakage.

Trade-secret protection requires more than believing information is confidential. The Defend Trade Secrets Act provides a civil remedy for trade-secret misappropriation. 18 U.S.C. § 1836(b). But the statutory definition of a trade secret requires that the owner take "reasonable measures" to keep the information secret and that the information derive independent economic value from not being generally known or readily ascertainable. 18 U.S.C. § 1839(3).

For CPG companies, reasonable measures often include clean supplier agreements, invention-assignment terms, confidentiality controls, limited access to formulas and process parameters, version tracking, visitor protocols, and clear ownership of improvements made during scale-up.

The common failure is assuming the NDA solves everything. It does not. If a supplier improves the filling process, develops a new fitment, changes the tooling, or solves a stability issue, who owns that improvement? Can the supplier use it for competitors? Can the company file patents on it? Can either party disclose it? If the agreement is silent, the business may discover the answer only when the asset is already contested.


Lost Opportunity 7: Separating Patent Strategy from Margin Strategy

The best CPG IP programs are not filing programs. They are value programs.

A patent claim that protects a low-margin feature no one copies may be less valuable than a trade-secret process that preserves yield. A design patent on a hero package may matter more than a narrow utility claim if the competitive threat is lookalike packaging. A utility patent on a dispensing mechanism may create licensing leverage across categories. A formulation patent may help in diligence, even if the company never plans to sue, because it shows investors or acquirers that the technical moat was documented early.

CPG leaders should connect IP review to business metrics:
  • Which product features drive gross margin?
  • Which packaging or process choices reduce returns, leakage, breakage, freight, or spoilage?
  • Which elements are visible and easy to copy?
  • Which elements are invisible and better kept secret?
  • Which innovations matter to strategic buyers, retailers, distributors, or licensees?
  • Which claims would actually matter if a competitor launched a similar SKU?

This is where IP becomes more than a legal expense. It becomes a way to preserve the value the business already worked to create.


A Practical CPG IP Capture Checklist

Before a product launch, packaging refresh, manufacturing change, or supplier scale-up, ask:
  • What changed technically, visually, operationally, or commercially?
  • Who contributed to the change, including suppliers and agencies?
  • Has anything been publicly disclosed, sold, offered for sale, sampled, pitched, posted, or shown at retail?
  • What would competitors copy if they could?
  • What can we detect in the market, and what would remain hidden?
  • Is patent, design-patent, trademark, trade-dress, copyright, or trade-secret protection the better fit?
  • Are contracts aligned with ownership, confidentiality, patent filing rights, and improvement rights?
  • If patents exist, are covered products properly marked?
  • Does the IP map connect to margins, strategic accounts, retailer channels, licensing, and exit value?

The companies that answer those questions early usually make better filing decisions. They also avoid the worst outcome: discovering after a competitor copies them that the most valuable rights were never captured.


Closing Thought

CPG companies do not need bigger patent budgets as much as they need better IP capture habits. The opportunity is already in the business: in the formula notebook, the package file, the supplier call, the line trial, the consumer test, the margin analysis, and the launch calendar.

The legal work starts by seeing those moments before they become old news.


About SchellIP

Schell IP helps growth companies and innovation teams turn product, packaging, manufacturing, and brand-development work into practical IP strategy. Learn more at schellip.com. Schell IP is a proud part of Whiteford.

Selected Legal Authorities

  • 35 U.S.C. § 102(a)(1), (b)(1) (novelty; public disclosures and limited U.S. grace-period exceptions).
  • 35 U.S.C. § 103; KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398 (2007) (obviousness).
  • 35 U.S.C. § 171 (design patents for ornamental designs for articles of manufacture).
  • 35 U.S.C. § 289; Samsung Electronics Co. v. Apple Inc., 580 U.S. 53 (2016) (design patent damages and "article of manufacture").
  • 35 U.S.C. § 287(a) (patent marking and damages notice).
  • 15 U.S.C. § 1125(a), including § 1125(a)(3) (unregistered trade dress and non-functionality burden).
  • Wal-Mart Stores, Inc. v. Samara Bros., Inc., 529 U.S. 205 (2000) (product-design trade dress and secondary meaning).
  • TrafFix Devices, Inc. v. Marketing Displays, Inc., 532 U.S. 23 (2001) (functionality and trade dress).
  • Qualitex Co. v. Jacobson Products Co., 514 U.S. 159 (1995) (color as trademark in appropriate circumstances).
  • 18 U.S.C. §§ 1836(b), 1839(3) (Defend Trade Secrets Act civil remedy and trade-secret definition).
The information contained here is not intended to provide legal advice or opinion and should not be acted upon without consulting an attorney. Counsel should not be selected based on advertising materials, and we recommend that you conduct further investigation when seeking legal representation.